Browsing by Author "Kodaz, Hilmi"
Now showing items 1-3 of 3
-
Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology
Demirci, Umut; Oflazoglu, Utku; Kodaz, Hilmi; Ciltas, Aydin; Kefeli, Umut; Akyol, Murat; Ozturk, Banu; Geredell, Caglayan; Seker, Mehmet Metin; Clhan, Saner; Tastekin, Dldem; Sevinc, Alper; Akinci, Muhammad Bulent; Uysal, Mukremin; Taskoylu, Burcu Yapar; Duran, Ayse Ocak; Yazici, Omer Komi; Karaoglu, Aziz; Benekli, Mustafa; Buyukberber, Suleyman (AMER SOC CLINICAL ONCOLOGY, 2014)… -
Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO)
Esbah, Onur; Demirci, Umut; Dane, Faysal; Gunaydsin, Yusuf; Ozdemir, Nuriye; Ekinci, Ahmet Siyar; Kodaz, Hilmi; Yazilitas, Dogan; Rzayev, Rashad; Guney, Yildiz; Seker, Metin; Uysal, Mukremin; Inal, Ali; Bilici, Ahmet; Benekli, Mustafa; Oksuzoglu, Berna; Buyukberber, Suleyman (ZERBINIS MEDICAL PUBL, 2016)Purpose: Medulloblastoma (MB) is rarely seen in adults. For adjuvant therapy in adults the same therapy protocols used in pediatric cases are used. The present study retrospectively evaluated the data of MB patients who ... -
Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)
Inal, Ali; Kodaz, Hilmi; Odabas, Hatice; Duran, Ayse Ocak; Seker, Mehmet Metin; Inanc, Mevlide; Elkiran, Emin Tamer; Gunaydin, Yusuf; Menekse, Serkan; Topcu, Turkan Ozturk; Urakci, Zuhat; Tastekin, Didem; Bilici, Mehmet; Cihan, Sener; Geredeli, Caglayan; Sezer, Emel; Uncu, Dogan; Arpaci, Erkan; Ozturk, Banu; Bal, Oznur; Uysal, Mukremin; Tanriverdi, Ozgur; Gumus, Mahmut; Ustaalioglu, Bala Basak Oven; Suner, Ali; Cokmert, Suna; Hacibekiroglu, Ilhan; Aydin, Kubra; Isikdogan, Abdurrahman (MEDKNOW PUBLICATIONS & MEDIA PVT LTD, 2018)Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the ...